Axsome Therapeutics
AXSM
AXSM
290 hedge funds and large institutions have $3.15B invested in Axsome Therapeutics in 2024 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 91 increasing their positions, 90 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 90
3.85% less ownership
Funds ownership: 80.56% → 76.71% (-3.8%)
9% less capital invested
Capital invested by funds: $3.47B → $3.15B (-$328M)
Holders
290
Holding in Top 10
11
Calls
$181M
Puts
$121M
Top Buyers
| 1 | +$38.2M | |
| 2 | +$28.9M | |
| 3 | +$17.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.1M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$14.5M |
Top Sellers
| 1 | -$77M | |
| 2 | -$75.4M | |
| 3 | -$44.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$39.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$30.2M |